Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 09:52AM ET
6.40
Dollar change
+0.10
Percentage change
1.59
%
Index- P/E- EPS (ttm)-0.49 Insider Own- Shs Outstand16.53M Perf Week0.95%
Market Cap106.50M Forward P/E- EPS next Y-0.07 Insider Trans- Shs Float8.24M Perf Month3.56%
Income-8.19M PEG- EPS next Q-0.01 Inst Own23.85% Short Float1.94% Perf Quarter3.73%
Sales28.79M P/S3.70 EPS this Y64.26% Inst Trans- Short Ratio0.91 Perf Half Y96.92%
Book/sh2.48 P/B2.58 EPS next Y49.07% ROA-12.85% Short Interest0.16M Perf Year229.90%
Cash/sh2.65 P/C2.41 EPS next 5Y- ROE-18.18% 52W Range1.38 - 7.61 Perf YTD-1.23%
Dividend Est.- P/FCF- EPS past 5Y3.35% ROI-17.75% 52W High-15.96% Beta1.22
Dividend TTM- Quick Ratio5.94 Sales past 5Y15.62% Gross Margin73.09% 52W Low363.77% ATR (14)0.42
Dividend Ex-Date- Current Ratio6.36 EPS Y/Y TTM24.64% Oper. Margin-32.88% RSI (14)51.98 Volatility6.69% 7.08%
Employees134 Debt/Eq0.12 Sales Y/Y TTM-2.79% Profit Margin-28.45% Recom1.00 Target Price9.60
Option/ShortNo / Yes LT Debt/Eq0.12 EPS Q/Q95.45% Payout- Rel Volume0.96 Prev Close6.30
Sales Surprise7.22% EPS Surprise77.63% Sales Q/Q60.64% EarningsMar 06 BMO Avg Volume174.82K Price6.40
SMA202.41% SMA50-0.21% SMA20056.02% Trades Volume17,331 Change1.59%
Date Action Analyst Rating Change Price Target Change
Nov-16-23Downgrade Raymond James Outperform → Mkt Perform
Mar-03-22Initiated Loop Capital Buy $15
Jul-19-21Initiated H.C. Wainwright Buy $17
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
Feb-21-24 08:00AM
Feb-06-24 03:51PM
Jan-25-24 08:32AM
Jan-10-24 07:30AM
Jan-03-24 08:50AM
09:55AM Loading…
Dec-27-23 09:55AM
Dec-22-23 09:40AM
07:10AM
Dec-19-23 07:30AM
Dec-14-23 08:50AM
Dec-11-23 09:55AM
Dec-08-23 08:16AM
Dec-07-23 08:00AM
Nov-29-23 12:00PM
Nov-28-23 01:29PM
08:50AM Loading…
08:50AM
Nov-23-23 09:55AM
Nov-20-23 07:30AM
Nov-15-23 07:30AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
Oct-24-23 09:40AM
Oct-16-23 07:30AM
Oct-06-23 09:40AM
Sep-27-23 08:00AM
Sep-20-23 07:30AM
Sep-13-23 09:40AM
Sep-05-23 07:30AM
Aug-28-23 10:41AM
09:40AM
07:30AM Loading…
Aug-23-23 07:30AM
06:00AM
Aug-09-23 07:30AM
Aug-03-23 08:00AM
Jul-26-23 08:00AM
Jul-11-23 07:30AM
Jun-21-23 08:00AM
May-23-23 07:30AM
May-17-23 07:30AM
May-15-23 08:00AM
May-12-23 09:55AM
May-03-23 08:00AM
May-02-23 08:00AM
Mar-28-23 08:00AM
Mar-15-23 07:30AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-23-23 08:00AM
Feb-13-23 07:30AM
07:30AM
Feb-01-23 08:00AM
Jan-31-23 08:00AM
Jan-11-23 08:00AM
Jan-10-23 12:27PM
08:00AM
07:47AM
Dec-13-22 09:15AM
Nov-28-22 07:30AM
Nov-16-22 07:30AM
Nov-03-22 08:00AM
Nov-02-22 08:00AM
Nov-01-22 08:00AM
Oct-12-22 08:00AM
Oct-11-22 08:00AM
Sep-20-22 09:00AM
Sep-14-22 07:30AM
Aug-31-22 09:00AM
Aug-29-22 11:31AM
11:15AM
08:00AM
Aug-11-22 02:50PM
Aug-10-22 07:30AM
Jul-27-22 08:00AM
Jul-26-22 12:00PM
Jul-13-22 09:55AM
04:23AM
Jun-28-22 08:00AM
Jun-22-22 08:00AM
Jun-21-22 08:00AM
May-11-22 07:30AM
May-09-22 08:00AM
May-04-22 08:00AM
May-02-22 08:46AM
Apr-27-22 08:00AM
Mar-28-22 08:00AM
Mar-15-22 08:00AM
Mar-09-22 07:30AM
Mar-01-22 08:00AM
Feb-28-22 08:00AM
Feb-23-22 08:00AM
Feb-01-22 08:00AM
Jan-31-22 07:30AM
Jan-26-22 08:00AM
Jan-12-22 08:00AM
Dec-09-21 07:30AM
Nov-30-21 08:00AM
Nov-17-21 07:30AM
Nov-05-21 12:00PM
Nov-03-21 08:00AM
Oct-12-21 09:00AM
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.